Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership2,034,276 shares
Latest Disclosed Value $ 16,542,370
Geode Capital Management, Llc reports 0.28% increase in ownership of KUR / Kura Oncology, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 2,034,276 shares of Kura Oncology, Inc. (DE:KUR) valued at $13,527,935 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,028,618 shares of Kura Oncology, Inc.. This represents a change in shares of 0.28% during the quarter. The current value of the position is $15,379,127 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM 50127T109 2,034,276 5,658 0.28 16,542 -21.53 0.0005
2026-02-09 2025-12-31 13F KURA ONCOLOGY COM 50127T109 2,028,618 -19,308 -0.94 21,082 16.30 0.0013
2025-11-12 2025-09-30 13F KURA ONCOLOGY COM 50127T109 2,047,926 33,897 1.68 18,128 55.97 0.0012
2025-08-08 2025-06-30 13F KURA ONCOLOGY COM 50127T109 2,014,029 211,470 11.73 11,623 -2.33 0.0008
2025-05-13 2025-03-31 13F KURA ONCOLOGY COM 50127T109 1,802,559 20,515 1.15 11,900 -23.36 0.0009
2025-02-12 2024-12-31 13F KURA ONCOLOGY COM 50127T109 1,782,044 1,535 0.09 15,525 -55.38 0.0012
2024-11-12 2024-09-30 13F KURA ONCOLOGY COM 50127T109 1,780,509 41,535 2.39 34,798 -2.83 0.0028
2024-08-09 2024-06-30 13F KURA ONCOLOGY COM 50127T109 1,738,974 31,700 1.86 35,813 -1.67 0.0031
2024-05-13 2024-03-31 13F KURA ONCOLOGY COM 50127T109 1,707,274 51,265 3.10 36,421 52.93 0.0034
2024-02-13 2023-12-31 13F KURA ONCOLOGY COM 50127T109 1,656,009 78,053 4.95 23,816 65.48 0.0025
2023-11-13 2023-09-30 13F KURA ONCOLOGY COM 50127T109 1,577,956 249,840 18.81 14,393 2.43 0.0017
2023-08-11 2023-06-30 13F KURA ONCOLOGY COM 50127T109 1,328,116 41,576 3.23 14,051 -10.70 0.0017
2023-05-15 2023-03-31 13F KURA ONCOLOGY COM 50127T109 1,286,540 57,110 4.65 15,734 104,793.33 0.0020
2023-02-13 2022-12-31 13F KURA ONCOLOGY COM 50127T109 1,229,430 39,675 3.33 15 -99.91 0.0021
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 1,189,755 -14,555 -1.21 16,252 -26.38 0.0025
2022-08-12 2022-06-30 13F KURA ONCOLOGY COM 50127T109 1,204,310 96,533 8.71 22,075 23.93 0.0032
2022-05-13 2022-03-31 13F KURA ONCOLOGY COM 50127T109 1,107,777 -96,049 -7.98 17,813 5.70 0.0022
2022-02-11 2021-12-31 13F KURA ONCOLOGY COM 50127T109 1,203,826 100,066 9.07 16,853 -18.48 0.0020
2021-11-12 2021-09-30 13F KURA ONCOLOGY COM 50127T109 1,103,760 -46,397 -4.03 20,673 -13.79 0.0028
2021-08-13 2021-06-30 13F KURA ONCOLOGY COM 50127T109 1,150,157 62,700 5.77 23,980 -22.00 0.0033
2021-05-12 2021-03-31 13F KURA ONCOLOGY COM 50127T109 1,087,457 91,966 9.24 30,742 -5.44 0.0047
2021-02-12 2020-12-31 13F KURA ONCOLOGY COM 50127T109 995,491 160,911 19.28 32,512 27.14 0.0055
2020-11-13 2020-09-30 13F KURA ONCOLOGY COM 50127T109 834,580 93,712 12.65 25,571 111.75 0.0050
2020-08-13 2020-06-30 13F KURA ONCOLOGY COM 50127T109 740,868 159,884 27.52 12,076 108.93 0.0026
2020-05-14 2020-03-31 13F KURA ONCOLOGY COM 50127T109 580,984 60,842 11.70 5,780 -19.17 0.0015
2020-02-20 2019-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 520,142 21,110 4.23 7,151 -5.54 0.0015
2020-02-13 2019-12-31 13F KURA ONCOLOGY COM 50127T109 520,142 21,110 7,151 911.3322
2019-11-12 2019-09-30 13F KURA ONCOLOGY COM 50127T109 499,032 57,702 13.07 7,570 -12.88 0.0018
2019-08-14 2019-06-30 13F KURA ONCOLOGY COM 50127T109 441,330 67,546 18.07 8,689 40.12 0.0021
2019-05-14 2019-03-31 13F KURA ONCOLOGY COM 50127T109 373,784 19,774 5.59 6,201 24.77 0.0016
2019-03-06 2018-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 354,010 43,205 13.90 4,970 -8.62 0.0015
2019-02-13 2018-12-31 13F KURA ONCOLOGY COM 50127T109 354,010 43,205 4,970
2018-11-13 2018-09-30 13F KURA ONCOLOGY COM 50127T109 310,805 35,794 13.02 5,439 8.67 0.0015
2018-08-14 2018-06-30 13F KURA ONCOLOGY COM 50127T109 275,011 41,680 17.86 5,005 14.43 0.0015
2018-05-15 2018-03-31 13F KURA ONCOLOGY COM 50127T109 233,331 66,417 39.79 4,374 71.33 0.0014
2018-02-13 2017-12-31 13F KURA ONCOLOGY COM 50127T109 166,914 3,255 1.99 2,553 4.37 0.0009
2017-11-14 2017-09-30 13F KURA ONCOLOGY COM 50127T109 163,659 90,740 124.44 2,446 260.77 0.0009
2017-08-14 2017-06-30 13F KURA ONCOLOGY COM 50127T109 72,919 23,237 46.77 678 55.15 0.0003
2017-06-21 2017-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 49,682 426 0.86 437 50.69 0.0002
2017-05-12 2017-03-31 13F KURA ONCOLOGY COM 50127T109 49,682 437
2017-02-14 2016-12-31 13F KURA ONCOLOGY COM 50127T109 49,256 284 0.58 290 -5.23 0.0001
2016-11-10 2016-09-30 13F KURA ONCOLOGY COM 50127T109 48,972 48,972 306 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.